|
WDR20 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.97060000223837E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.1588999999933E-05 |
| Normal-vs-Stage2 |
1.465970E-02 |
| Normal-vs-Stage3 |
9.67770000026569E-07 |
| Normal-vs-Stage4 |
7.09300396195545E-11 |
| Stage1-vs-Stage2 |
3.365200E-01 |
| Stage1-vs-Stage3 |
1.521350E-01 |
| Stage1-vs-Stage4 |
3.185400E-04 |
| Stage2-vs-Stage3 |
9.664100E-02 |
| Stage2-vs-Stage4 |
1.695210E-03 |
| Stage3-vs-Stage4 |
1.295250E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.69939999639502E-08 |
| Normal-vs-AfricanAmerican |
2.656600E-03 |
| Normal-vs-Asian |
3.6543E-05 |
| Caucasian-vs-AfricanAmerican |
6.255000E-01 |
| Caucasian-vs-Asian |
4.325600E-01 |
| AfricanAmerican-vs-Asian |
9.823600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.70809999999944E-05 |
| Normal-vs-Female |
6.48819999948813E-08 |
| Male-vs-Female |
6.352200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.58990000000059E-05 |
| Normal-vs-Age(41-60Yrs) |
1.26710000003527E-06 |
| Normal-vs-Age(61-80Yrs) |
6.44559999818384E-08 |
| Normal-vs-Age(81-100Yrs) |
3.80650000000315E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.790400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.802500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.072200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.241200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.587800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.555380E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.368000E-04 |
| Classical-VS-Follicular |
1.132780E-01 |
| Classical-VS-Other |
7.639400E-01 |
| Classical-VS-Normal |
1.35260000000414E-06 |
| Tall-VS-Follicular |
1.207820E-04 |
| Tall-VS-Other |
3.278100E-02 |
| Tall-VS-Normal |
1.98000005280363E-09 |
| Follicular-VS-Other |
7.713000E-01 |
| Follicular-VS-Normal |
2.740300E-02 |
| Other-VS-Normal |
8.710500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.33589999999451E-05 |
| Normal-vs-N1 |
4.2552000034668E-08 |
| N0-vs-N1 |
1.892230E-02 |
|
|
